216 related articles for article (PubMed ID: 23624753)
21. Ellagic Acid Prevents Ca
Yamasan BE; Mercan T; Erkan O; Ozdemir S
Cardiovasc Toxicol; 2021 Aug; 21(8):630-641. PubMed ID: 33909254
[TBL] [Abstract][Full Text] [Related]
22. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
23. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats.
Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L
J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128
[TBL] [Abstract][Full Text] [Related]
24. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
25. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure.
Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M
Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957
[TBL] [Abstract][Full Text] [Related]
26. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
[TBL] [Abstract][Full Text] [Related]
27. Songling Xuemaikang Capsule inhibits isoproterenol-induced cardiac hypertrophy via CaMKIIδ and ERK1/2 pathways.
Qi J; Tan Y; Fan D; Pan W; Yu J; Xu W; Wu J; Zhang M
J Ethnopharmacol; 2020 May; 253():112660. PubMed ID: 32061912
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-Activated Protein Kinase and Intracellular Polyamine Signaling Is Involved in TRPV1 Activation-Induced Cardiac Hypertrophy.
Chen M; Xin J; Liu B; Luo L; Li J; Yin W; Li M
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473037
[TBL] [Abstract][Full Text] [Related]
29. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
[TBL] [Abstract][Full Text] [Related]
30. Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.
Chen X; Nakayama H; Zhang X; Ai X; Harris DM; Tang M; Zhang H; Szeto C; Stockbower K; Berretta RM; Eckhart AD; Koch WJ; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2011 Mar; 50(3):460-70. PubMed ID: 21111744
[TBL] [Abstract][Full Text] [Related]
31. Calmodulin kinases II and IV and calcineurin are involved in leukemia inhibitory factor-induced cardiac hypertrophy in rats.
Kato T; Sano M; Miyoshi S; Sato T; Hakuno D; Ishida H; Kinoshita-Nakazawa H; Fukuda K; Ogawa S
Circ Res; 2000 Nov; 87(10):937-45. PubMed ID: 11073891
[TBL] [Abstract][Full Text] [Related]
32. Betulinic Acid Protects DOX-Triggered Cardiomyocyte Hypertrophy Response through the GATA-4/Calcineurin/NFAT Pathway.
Yoon JJ; Son CO; Kim HY; Han BH; Lee YJ; Lee HS; Kang DG
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374365
[TBL] [Abstract][Full Text] [Related]
33. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J
Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566
[TBL] [Abstract][Full Text] [Related]
34. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional upregulation of calcineurin Abeta by endothelin-1 is partially mediated by calcium/calmodulin-dependent protein kinase IIdelta3 in rat cardiomyocytes.
Lu YM; Shioda N; Yamamoto Y; Han F; Fukunaga K
Biochim Biophys Acta; 2010; 1799(5-6):429-41. PubMed ID: 20215061
[TBL] [Abstract][Full Text] [Related]
36. Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling.
Yan L; Huang H; Tang QZ; Zhu LH; Wang L; Liu C; Bian ZY; Li H
J Cell Biochem; 2010 Apr; 109(6):1158-71. PubMed ID: 20127712
[TBL] [Abstract][Full Text] [Related]
37. Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.
Wang Y; Keskanokwong T; Cheng J
J Mol Cell Cardiol; 2019 Jan; 126():77-85. PubMed ID: 30462989
[TBL] [Abstract][Full Text] [Related]
38. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
[TBL] [Abstract][Full Text] [Related]
39. Cardiac CaM Kinase II genes δ and γ contribute to adverse remodeling but redundantly inhibit calcineurin-induced myocardial hypertrophy.
Kreusser MM; Lehmann LH; Keranov S; Hoting MO; Oehl U; Kohlhaas M; Reil JC; Neumann K; Schneider MD; Hill JA; Dobrev D; Maack C; Maier LS; Gröne HJ; Katus HA; Olson EN; Backs J
Circulation; 2014 Oct; 130(15):1262-73. PubMed ID: 25124496
[TBL] [Abstract][Full Text] [Related]
40. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
